1. A BRAF new world. (August 2020) Authors: Frisone, Daniele; Friedlaender, Alex; Malapelle, Umberto; Banna, Giuseppe; Addeo, Alfredo Journal: Critical reviews in oncology/hematology Issue: Volume 152(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ADAURA: Mature Enough for Publication, Not for Prime Time. (24th December 2020) Authors: Addeo, Alfredo; Banna, Giuseppe Luigi; Friedlaender, Alex Journal: Oncologist Issue: Volume 26:Number 4(2021) Page Start: 266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Antibody Drug Conjugates in Lung Cancer. Issue 6 (November 2022) Authors: Merle, Geoffrey; Friedlaender, Alex; Desai, Aakash; Addeo, Alfredo Journal: Cancer journal Issue: Volume 28:Issue 6(2022) Page Start: 429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation. Issue 2 (19th October 2020) Authors: Cortellini, Alessio; Ricciuti, Biagio; Tiseo, Marcello; Bria, Emilio; Banna, Giuseppe L; Aerts, Joachim GJV; Barbieri, Fausto; Giusti, Raffaele; Cortinovis, Diego L; Migliorino, Maria R; Catino, Annamaria; Passiglia, Francesco; Torniai, Mariangela; Morabito, Alessandro; Genova, Carlo; Mazzoni, Fr... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation. Issue 2 (19th October 2020) Authors: Cortellini, Alessio; Ricciuti, Biagio; Tiseo, Marcello; Bria, Emilio; Banna, Giuseppe L; Aerts, Joachim GJV; Barbieri, Fausto; Giusti, Raffaele; Cortinovis, Diego L; Migliorino, Maria R; Catino, Annamaria; Passiglia, Francesco; Torniai, Mariangela; Morabito, Alessandro; Genova, Carlo; Mazzoni, Fr... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation. Issue 2 (19th October 2020) Authors: Cortellini, Alessio; Ricciuti, Biagio; Tiseo, Marcello; Bria, Emilio; Banna, Giuseppe L; Aerts, Joachim GJV; Barbieri, Fausto; Giusti, Raffaele; Cortinovis, Diego L; Migliorino, Maria R; Catino, Annamaria; Passiglia, Francesco; Torniai, Mariangela; Morabito, Alessandro; Genova, Carlo; Mazzoni, Fr... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation. Issue 2 (19th October 2020) Authors: Cortellini, Alessio; Ricciuti, Biagio; Tiseo, Marcello; Bria, Emilio; Banna, Giuseppe L; Aerts, Joachim GJV; Barbieri, Fausto; Giusti, Raffaele; Cortinovis, Diego L; Migliorino, Maria R; Catino, Annamaria; Passiglia, Francesco; Torniai, Mariangela; Morabito, Alessandro; Genova, Carlo; Mazzoni, Fr... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation. Issue 2 (19th October 2020) Authors: Cortellini, Alessio; Ricciuti, Biagio; Tiseo, Marcello; Bria, Emilio; Banna, Giuseppe L; Aerts, Joachim GJV; Barbieri, Fausto; Giusti, Raffaele; Cortinovis, Diego L; Migliorino, Maria R; Catino, Annamaria; Passiglia, Francesco; Torniai, Mariangela; Morabito, Alessandro; Genova, Carlo; Mazzoni, Fr... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation. Issue 2 (19th October 2020) Authors: Cortellini, Alessio; Ricciuti, Biagio; Tiseo, Marcello; Bria, Emilio; Banna, Giuseppe L; Aerts, Joachim GJV; Barbieri, Fausto; Giusti, Raffaele; Cortinovis, Diego L; Migliorino, Maria R; Catino, Annamaria; Passiglia, Francesco; Torniai, Mariangela; Morabito, Alessandro; Genova, Carlo; Mazzoni, Fr... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation. Issue 2 (19th October 2020) Authors: Cortellini, Alessio; Ricciuti, Biagio; Tiseo, Marcello; Bria, Emilio; Banna, Giuseppe L; Aerts, Joachim GJV; Barbieri, Fausto; Giusti, Raffaele; Cortinovis, Diego L; Migliorino, Maria R; Catino, Annamaria; Passiglia, Francesco; Torniai, Mariangela; Morabito, Alessandro; Genova, Carlo; Mazzoni, Fr... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗